☆ 4.6 Review

Desensitization in Crossmatch-positive Kidney Transplant Candidates

TRANSPLANTATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Surgery

Clazakizumab for desensitization in highly sensitized patients awaiting transplantation

Ashley A. Vo et al.

Summary: This study aimed to evaluate the desensitization treatment effect for highly HLA-sensitized patients using clazakizumab. The results showed that desensitization treatment with clazakizumab could effectively reduce HLA antibody levels in highly sensitized patients, leading to a higher success rate of transplantation. Posttransplant, significant increases in T-reg and B-reg cells were observed, while antibody-mediated rejection also occurred.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

添加到收藏夹

Article Surgery

Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates

Thomas Jouve et al.

Summary: In highly sensitized kidney transplant candidates, tocilizumab as a monotherapy limited B cell maturation while having almost no effect on anti-HLA alloantibodies.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

添加到收藏夹

Article Urology & Nephrology

Immortal Time-Bias-Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients

Johan Noble et al.

Summary: HLA desensitization is effective for highly sensitized patients in kidney transplantation, providing access to KT without adverse effects on patient or graft survival rates.

KIDNEY INTERNATIONAL REPORTS (2021)

添加到收藏夹

Article Immunology

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

Stanley C. Jordan et al.

Summary: This study investigated the efficacy and safety of imlifidase in converting a positive crossmatch test to negative in highly sensitized patients, allowing them to undergo kidney transplantation. Results showed that majority of transplanted patients achieved negative crossmatch within 24 hours after imlifidase treatment, with good kidney function and graft survival at 6 months.

TRANSPLANTATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine Models

Jordi Guiteras et al.

Summary: The study demonstrates the efficacy of HYBRI, a fusion protein containing CTLA4 and PD-L2 domains, in reducing inflammation and improving survival in rat kidney models of injury and transplant rejection. HYBRI shows promise as a potential therapeutic intervention for ischemia-reperfusion injury and solid organ transplantation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Hematology

Efficacy of plasmapheresis and semi-selective immunoadsorption for removal of anti-HLA antibodies

Frederic Jambon et al.

Summary: This study compared the efficacy of PP and IA in removing anti-HLA antibodies, and found that IA had a stronger MFI reduction than PP in the extended apheresis protocol. For antibodies with an initial MFI < 3000, there was no superiority of IA over PP in the short protocol. Residual MFI predicted the effectiveness of four additional sessions for antibodies with an initial MFI >= 2000.

JOURNAL OF CLINICAL APHERESIS (2021)

添加到收藏夹

Article Hematology

Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants

Prashant Pandey et al.

Summary: The study compared the outcomes of renal transplant recipients across simultaneous ABO and HLA incompatibility barriers to those with ABO or HLA incompatibility alone, and found that patient and graft outcomes with incompatible transplants were not worse than those with compatible transplants.

JOURNAL OF CLINICAL APHERESIS (2021)

添加到收藏夹

Article Urology & Nephrology

A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

Konstantin Doberer et al.

Summary: This study was a phase 2 randomized trial evaluating the safety and efficacy of the anti-IL-6 antibody clazakizumab in late antibody-mediated rejection (ABMR) post-transplantation. Results showed that patients receiving clazakizumab had decreased donor-specific antibodies and modulated rejection-related gene-expression patterns.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Review Immunology

Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19

Alice R. Burton et al.

Summary: Humoral immunity plays a critical role in resolving viral infections and providing protection, with factors shaping memory B cell responses allowing tailored development of efficient preventative vaccines. Lessons can be learned from different viral infections, including hepatitis B, regarding the diverse influences on humoral immunity.

IMMUNOLOGICAL REVIEWS (2021)

添加到收藏夹

Article Hematology

Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis

Raphael Marlu et al.

Summary: The study found that DFPP was more effective in depleting high molecular-weight proteins compared to cTPE and mTPE, while all plasma exchange methods led to significant reductions in fibrinogen and FXIII.

JOURNAL OF CLINICAL APHERESIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates

Roy Sriwattanakomen et al.

Summary: The study summarizes the experience of desensitization using carfilzomib in heart transplant candidates. Through multiple cycles of treatment, the level of HLA antibodies was significantly reduced, facilitating successful transplantation. The post-transplant survival rate was high, with a low occurrence of rejection episodes.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

添加到收藏夹

Article Urology & Nephrology

Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time

Tai Yeon Koo et al.

Summary: HLA-incompatible living donor kidney transplantation may have better patient survival rate and survival benefit compared to waiting for HLA-compatible deceased donor kidney transplantation for sensitized patients with kidney failure in Korea.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Article Immunology

BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization

Divyansh Agarwal et al.

Summary: In highly sensitized kidney transplant candidates, BLyS blockade did not significantly reduce total anti-HLA allo-Ab levels but resulted in selective depletion of antibodies recognizing specific HLA allele specificities.

TRANSPLANT IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation

Maria Meneghini et al.

Summary: Molecular HLA mismatches between donors and recipients may impact the development of posttransplant T-cell alloimmunity and subsequent donor-specific cellular and humoral alloimmune activation. These immune responses are influenced by the degree of HLA molecular incompatibility between donors and recipients, as well as the pretransplant cellular immune status of the patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Surgery

Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial

Oriol Bestard et al.

Summary: Personalizing immunosuppression in kidney transplant recipients with low immunological risk through biomarker-guided trials of tacrolimus monotherapy was found to be non-inferior to standard of care in terms of 6-month biopsy-proven acute rejection rates. However, recruitment challenges led to the early termination of the trial.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Hematology

Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption

Thomas Jouve et al.

Summary: Fibrinogen reconstitution after therapeutic apheresis is highly variable among patients and apheresis sessions. Different apheresis modalities have a significant impact on fibrinogen reconstitution, regardless of hemoconcentration.

JOURNAL OF CLINICAL APHERESIS (2021)

添加到收藏夹

Review Immunology

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers

Nizar Joher et al.

Summary: The presence of anti-HLA antibodies is a major barrier to solid organ transplantation. Desensitization protocols have shown improvements in transplantation rates but limitations still exist, prompting interest in new desensitization approaches focused on targeting alloimmune pathways beyond antibodies. Targeting CD38 to desensitize in the field of transplantation is an emerging concept worth further exploration.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation

Johan Noble et al.

Summary: This study evaluated the efficacy and tolerance of different techniques in removing donor specific antibodies in HLA-incompatible kidney transplant patients. The results showed that plasma exchange and other methods were effective in reducing antibody levels, allowing highly sensitized patients to undergo successful HLA-incompatible kidney transplantation with good safety outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Surgery

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

Nathalie Chavarot et al.

Summary: Poor responses to mRNA COVID-19 vaccine were observed in kidney transplant recipients treated with belatacept, especially in those without prior COVID-19 history. However, patients with a history of COVID-19 developed a strong antibody response with high titers after vaccination. Further strategies are needed to improve protection in this population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Surgery

Outcomes at 3 years post-transplant in imlifidase-desensitized kidney transplant patients

Christian Kjellman et al.

Summary: Imlifidase is a cysteine proteinase that can cleave IgG and convert a positive crossmatch to negative, enabling kidney transplantation between previously HLA incompatible pairs. Studies have shown that recipients of imlifidase-enabled allografts have comparable outcomes to other highly sensitized patients undergoing HLA-incompatible transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Immunology

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept

Michael T. Ou et al.

Summary: The study examined the immunogenicity after SARS-CoV-2 mRNA vaccines in kidney transplant recipients taking belatacept and those who are not. Belatacept use was associated with lower odds of having a positive post-D2 titer result, indicating the need for additional measures to protect kidney transplant recipients taking belatacept.

TRANSPLANTATION (2021)

添加到收藏夹

Article Transplantation

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

Melanie Daligault et al.

Summary: The administration of tocilizumab as a monotherapy was found to significantly reduce dominant anti-HLA antibody sensitization in highly sensitized kidney transplant candidates. However, the decrease in mean fluorescence intensities was minor compared with the initial values, indicating that tocilizumab alone was not an effective desensitization method for these candidates.

TRANSPLANTATION DIRECT (2021)

添加到收藏夹

Article Surgery

A prospective, iterative, adaptive trial of carfilzomib-based desensitization

Simon Tremblay et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Article Surgery

How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade

Kyle R. Jackson et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Article Surgery

Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients

Dharmendra Jain et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Article Surgery

Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition

Shudhanshu Alishetti et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Article Hematology

Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters

Raphael Marlu et al.

JOURNAL OF CLINICAL APHERESIS (2020)

添加到收藏夹

Article Surgery

Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients

Christopher K. Burghuber et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

添加到收藏夹

Article Immunology

New insights into the development of B cell responses: Implications for solid organ transplantation

Anita S. Chong

HUMAN IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice

Nancy A. Wilson et al.

TRANSPLANTATION (2019)

添加到收藏夹

Article Surgery

Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies

Denis Glotz et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

添加到收藏夹

Article Surgery

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

Robert R. Redfield et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

添加到收藏夹

Article Urology & Nephrology

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use

Jean Kwun et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model

Natalie M. Bath et al.

PLOS ONE (2019)

添加到收藏夹

Article Surgery

Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

William H. Marks et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Rituximab in kidney disease and transplant

Kajal Chauhan et al.

ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2019)

添加到收藏夹

Review Surgery

An unjustified benefit: immortal time bias in the analysis of time-dependent events

Andreas Gleiss et al.

TRANSPLANT INTERNATIONAL (2018)

添加到收藏夹

Article Surgery

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

Tomas Lorant et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

添加到收藏夹

Article Surgery

Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT

R. A. Bray et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

添加到收藏夹

Article Surgery

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies

R. A. Bray et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

添加到收藏夹

Article Surgery

IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody

Bonnie E. Lonze et al.

ANNALS OF SURGERY (2018)

添加到收藏夹

Review Medicine, General & Internal

Antibody-Mediated Rejection of Solid-Organ Allografts

Alexandre Loupy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes

Imogen Moran et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Medicine, General & Internal

Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis

Miriam Manook et al.

LANCET (2017)

添加到收藏夹

Article Medicine, General & Internal

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

S. C. Jordan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Immunology

32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody

Manuel A. Moreno Gonzales et al.

TRANSPLANTATION (2017)

添加到收藏夹

Article Immunology

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program

Lucile Amrouche et al.

TRANSPLANTATION (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Plasma cell survival in the absence of B cell memory

Erika Hammarlund et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Review Immunology

Desensitization: Overcoming the Immunologic Barriers to Transplantation

Supreet Sethi et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2017)

添加到收藏夹

Article Hematology

Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates

Jean Kwun et al.

BLOOD ADVANCES (2017)

添加到收藏夹

Article Surgery

Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients

J. Choi et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

添加到收藏夹

Article Urology & Nephrology

Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates

Ruth Sapir-Pichhadze et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Belatacept and Long-Term Outcomes in Kidney Transplantation

Flavio Vincenti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Immunology

Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients

Jianjun Chen et al.

JOURNAL OF IMMUNOLOGY (2015)

添加到收藏夹

Article Urology & Nephrology

A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation

Annette M. Jackson et al.

KIDNEY INTERNATIONAL (2015)

添加到收藏夹

Article Immunology

A Phase I/II Trial of the Interleukin-6 Receptor Specific Humanized Monoclonal (Tocilizumab) plus Intravenous Immunoglobulin in Difficult to Desensitize Patients

Ashley A. Vo et al.

TRANSPLANTATION (2015)

添加到收藏夹

Article Immunology

A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients

Ashley A. Vo et al.

TRANSPLANTATION (2015)

添加到收藏夹

Article Surgery

Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization

E. S. Woodle et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2015)

添加到收藏夹

Review Biochemical Research Methods

Tracking Plasma Cell Differentiation and Survival

Katrin Roth et al.

CYTOMETRY PART A (2014)

添加到收藏夹

Article Immunology

CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype

Griselda V. Zuccarino-Catania et al.

NATURE IMMUNOLOGY (2014)

添加到收藏夹

Article Surgery

Antibody-mediated rejection despite inhibition of terminal complement

Andrew Bentall et al.

TRANSPLANT INTERNATIONAL (2014)

添加到收藏夹

Article Immunology

Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

Ashley A. Vo et al.

TRANSPLANTATION (2014)

添加到收藏夹

Article Immunology

Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA-Incompatible Kidney Transplantation

Babak J. Orandi et al.

TRANSPLANTATION (2014)

添加到收藏夹

Article Immunology

Plasma Cell Homeostasis: The Effects of Chronic Antigen Stimulation and Inflammation

Tom Slocombe et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Urology & Nephrology

UK Renal Registry 16th Annual Report: Chapter 4 Demography of Patients Wait-listed for Renal Transplantation in the UK: National and Centre-specific Analyses

Rishi Pruthi et al.

NEPHRON CLINICAL PRACTICE (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Immunosuppression and HBV Reactivation

Daniel Shouval et al.

SEMINARS IN LIVER DISEASE (2013)

添加到收藏夹

Article Immunology

Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

Ashley A. Vo et al.

TRANSPLANTATION (2013)

添加到收藏夹

Article Immunology

Successful Kidney Transplantation After Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, and Rituximab in Highly Sensitized Patients: A Single-Center Experience

M. -K. Jin et al.

TRANSPLANTATION PROCEEDINGS (2012)

添加到收藏夹

Article Medicine, General & Internal

Desensitization in HLA-Incompatible Kidney Recipients and Survival

Robert A. Montgomery et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Review Immunology

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity

Ian J. Amanna et al.

IMMUNOLOGICAL REVIEWS (2010)

添加到收藏夹

Article Immunology

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

Ashley A. Vo et al.

TRANSPLANTATION (2010)

添加到收藏夹

Article Surgery

Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes

A. Haririan et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

添加到收藏夹

Article Immunology

Living Donor Kidney Transplantation Across Positive Crossmatch: The University of Illinois at Chicago Experience

James J. Thielke et al.

TRANSPLANTATION (2009)

添加到收藏夹

Article Medicine, General & Internal

Rituximab and intravenous immune globulin for desensitization during renal transplantation

Ashley A. Vo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Immunology

Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center's experience

Colm C. Magee et al.

TRANSPLANTATION (2008)

添加到收藏夹

Article Surgery

Analysis of subcutaneous (SQ) Alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and Rituximab

A. A. Vo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2008)

添加到收藏夹

Article Medicine, General & Internal

Duration of humoral immunity to common viral and vaccine antigens

Ian J. Amanna et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

Article Surgery

Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG

A. A. Vo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2006)

添加到收藏夹

Article Surgery

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody

MD Stegall et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2006)

添加到收藏夹

Article Urology & Nephrology

Evaluation of intravenous immunoglobulin as are agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIHIG02 trial

SC Jordan et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)

添加到收藏夹

Article Immunology

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

SC Jordan et al.

TRANSPLANTATION (2003)

添加到收藏夹

Article Surgery

Overcoming a positive crossmatch in living-donor kidney transplantation

JM Gloor et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2003)

添加到收藏夹

Article Surgery

Desensitization and subsequent transplantation kidney transplantation of patient using intravenous immunoglobulins (IVIg)

D Glotz et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2002)

添加到收藏夹

Article Transplantation

Peri-operative immunoadsorption in sensitized renal transplant recipients

M Haas et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)

添加到收藏夹

Article Immunology

A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants

EJ Schweitzer et al.

TRANSPLANTATION (2000)

添加到收藏夹

Article Immunology

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients

RA Montgomery et al.

TRANSPLANTATION (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.